IP Library Assignment 035553/0325
Patent Assignment
Reel/Frame 035553/0325

Change of Name

Recorded: 2015-04-30 Pages: 4
Assignor
BIOGEN IDEC HEMOPHILIA INC.
Executed: 2015-03-23
Assignee
BIOGEN HEMOPHILIA INC.
9 FOURTH AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties (26)
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Patent: 7,404,956 →
Application: 10/841,250 →
Publication: US 2005/0032174
Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins
Patent: 7,381,408 →
Application: 10/842,054 →
Publication: US 2005/0027109
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Patent: 7,348,004 →
Application: 11/029,003 →
Publication: US 2005/0260194
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Patent: 7,862,820 →
Application: 11/588,431 →
Publication: US 2007/0172928
Peptides That Block the Binding of Igg to Fcrn
Patent: 8,101,186 →
Application: 11/676,148 →
Publication: US 2007/0254831
Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins
Patent: 7,820,162 →
Application: 12/100,183 →
Publication: US 2008/0249288
Immunomodulatory Peptides
Application: 12/533,474 →
Publication: US 2010/0048488
PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn
Patent: 9,012,603 →
Application: 12/641,844 →
Publication: US 2011/0059889
Immunomodulatory Peptides
Patent: 8,906,844 →
Application: 12/671,883 →
Publication: US 2011/0230639
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Patent: 8,449,884 →
Application: 12/949,564 →
Publication: US 2011/0182896
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Patent: 8,329,182 →
Application: 12/952,551 →
Publication: US 2011/0182919
Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
Patent: 9,050,318 →
Application: 13/513,424 →
Publication: US 2013/0108629
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Patent: 8,932,830 →
Application: 13/667,951 →
Publication: US 2013/0171138
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Patent: 8,815,250 →
Application: 13/792,889 →
Publication: US 2013/0273047
Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
Patent: 9,241,978 →
Application: 13/793,783 →
Publication: US 2013/0274194
Factor IX Polypeptides and Methods of Use Thereof
Patent: 9,233,145 →
Application: 13/793,796 →
Publication: US 2013/0171175
Factor IX Polypeptides and Methods of Use Thereof
Patent: 9,670,475 →
Application: 13/809,276 →
Publication: US 2013/0202595
Systems for Factor Viii Processing and Methods Thereof
Patent: 9,611,310 →
Application: 13/809,285 →
Publication: US 2013/0281671
Processable Single Chain Molecules and Polypeptides Made Using Same
Patent: 9,856,468 →
Application: 13/809,287 →
Publication: US 2013/0202596
Chimeric Clotting Factors
Application: 13/809,289 →
Publication: US 2013/0216513
Factor Viii Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
Application: 14/131,600 →
Publication: US 2014/0294821
Assays to Monitor Bleeding Disorders
Application: 14/234,789 →
Publication: US 2015/0079072
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Application: 14/334,396 →
Publication: US 2015/0044207
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Patent: 9,636,416 →
Application: 14/530,256 →
Publication: US 2015/0139947
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Application: 90/013,242 →
Immunoglobulin Chimeric Monomer-Dimer Hybrids
Application: 90/013,296 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 1, 2004
From: PETERS, ROBERT T.; MEZO, ADAM R.; RIVERA, DANIEL S.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC
Reel/Frame 016044/0307 →
Assignment of Assignor's Interest Jan 3, 2006
From: PETERS, ROBERT T.; MEZO, ADAM R.; RIVERA, DANIEL S.; BITONI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 017160/0064 →
Assignment of Assignor's Interest Nov 9, 2006
From: PETERS, ROBERT T.; MEZO, ADAM R.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 018501/0574 →
Security Agreement Jan 12, 2007
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC INC.
Reel/Frame 018764/0586 →
Assignment of Assignor's Interest Feb 16, 2007
From: MEZO, ADAM R.; MCDONNELL, KEVIN A.; HEHIR, CRISTINA TAN; CASTRO, ALFREDO
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 018900/0629 →
Release & Reassignment Mar 5, 2007
From: BIOGEN IDEC INC.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 018964/0431 →
Assignment of Assignor's Interest Mar 4, 2009
From: MEZO, ADAM R.; PETERS, ROBERT T.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 022340/0055 →
Assignment of Assignor's Interest Mar 4, 2009
From: PETERS, ROBERT T.; MEZO, ADAM R.; RIVERA, DANIEL S.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 022340/0030 →
Assignment of Assignor's Interest Oct 27, 2009
From: MEZO, ADAM R.; MCDONNELL, KEVIN A.; DONNELLY, RYAN
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 023431/0099 →
Assignment of Assignor's Interest Jan 24, 2011
From: PETERS, ROBERT T.; MEZO, ADAM R.; RIVERA, DANIEL S.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 025683/0238 →
Assignment of Assignor's Interest Apr 8, 2011
From: RIVERA, DANIEL S.; PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 026097/0512 →
Assignment of Assignor's Interest Mar 28, 2013
From: RIVERA, DANIEL S.; PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 030104/0265 →
Assignment of Assignor's Interest Mar 28, 2013
From: PETERS, ROBERT T.; MEZO, ADAM R.; RIVERA, DANIEL S.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 030104/0235 →
Assignment of Assignor's Interest May 10, 2013
From: PIERCE, GLENN; TRUEX, SAMANTHA; PETERS, ROBERT T.; JIANG, HAIYAN
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 030389/0721 →
Assignment of Assignor's Interest Dec 6, 2013
From: PIERCE, GLENN; TRUEX, SAMANTHA; PETERS, ROBERT T.; JIANG, HAIYAN
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 031730/0427 →
Assignment of Assignor's Interest Dec 6, 2013
From: DUMONT, JENNIFER A.; LOW, SUSAN; BITONTI, ALAN J.; PIERCE, GLENN
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 031730/0449 →
Change of Name Jan 13, 2014
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 031997/0601 →
Change of Name Apr 3, 2014
From: SYNTONIX PHARMACEUTCIALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 032602/0053 →
Change of Name Apr 24, 2014
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 032753/0837 →
Corrective Assignment to Correct the Assignor Previously Recorded on Reel 032602 Frame 0053. Assignor(S) Hereby Confirms the Change of Name. Jun 5, 2014
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 033087/0015 →
Change of Name Aug 6, 2014
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 033482/0486 →
Assignment of Assignor's Interest Aug 7, 2014
From: MEZO, ADAM R.; MCDONNELL, KEVIN A.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 033490/0820 →
Change of Address Jul 2, 2015
From: BIOGEN HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 036051/0773 →
Change of Name Feb 16, 2017
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 041735/0703 →
Change of Name Feb 16, 2017
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 041735/0696 →